Hospital
Jackson County Healthcare Authority
Jackson County Healthcare Authority was paid $1.00M by Medicaid between Jan 2018 and Jan 2023, across 89 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 29% of everything it billed.
33Billing provider infoJACKSON COUNTY HEALTHCARE AUTHORITY
SCOTTSBORO, AL 35768
SCOTTSBORO, AL 35768
33aNPI1659473916assigned 09/05/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.00M
24GClaims66,881
24DCodes billed89
24AFirst – last monthJan 2018 – Jan 2023
Compared with peers
Next to other General Acute Care Hospital providers in Alabama
Rank by total paid#43 of 77
Median peer was paid$1.13M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,000 | $175K | |
| 2019 | 12,969 | $184K | |
| 2020 | 11,437 | $169K | |
| 2021 | 14,637 | $212K | |
| 2022 | 13,050 | $242K | |
| 2023 | 788 | $22K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 29% | 8,581 | 8,045 | $296K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 8,649 | 8,084 | $279K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.6% | 8,268 | 7,515 | $57K |
| 80053 | Comprehensive metabolic panel | 5.6% | 6,667 | 6,081 | $56K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.3% | 1,176 | 1,076 | $53K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.3% | 770 | 642 | $43K |
| 87631 | 3.7% | 592 | 544 | $37K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.6% | 3,136 | 2,674 | $26K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.3% | 560 | 438 | $23K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 2,518 | 1,231 | $18K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 472 | 441 | $10K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 556 | 139 | $9K |
77 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 905 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 503 | $7K |
| 80306 | <1% | 620 | $7K | |
| 84484 | <1% | 1,090 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,129 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 92 | $5K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 143 | $4K |
| 81000 | <1% | 1,486 | $4K | |
| 97032 | <1% | 409 | $4K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 277 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 386 | $4K |
| 82553 | <1% | 391 | $3K | |
| 87070 | <1% | 293 | $3K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 134 | $3K |
| 83874 | <1% | 394 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 103 | $2K |
| 83690 | <1% | 338 | $2K | |
| 82550 | <1% | 430 | $2K | |
| 86762 | <1% | 88 | $2K | |
| 81025 | <1% | 517 | $2K | |
| 99001 | <1% | 461 | $2K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 13 | $1K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 26 | $1K |
| 83880 | <1% | 70 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 140 | $1K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 53 | $918.69 |
| 87340 | <1% | 67 | $858.46 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 51 | $799.37 |
| 80305 | <1% | 129 | $795.72 | |
| 0011A | <1% | 18 | $720.00 | |
| 80061 | Lipid panel | <1% | 43 | $698.00 |
| 0012A | <1% | 17 | $680.00 | |
| 81003 | <1% | 285 | $607.61 | |
| 86850 | <1% | 90 | $528.75 | |
| 86592 | <1% | 104 | $523.13 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 687 | $471.51 |
| 82677 | <1% | 14 | $421.40 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | $365.64 |
| 84702 | <1% | 27 | $347.06 | |
| 82105 | <1% | 14 | $308.14 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $299.16 |
| 87150 | <1% | 12 | $284.24 | |
| 86336 | <1% | 14 | $267.40 | |
| 86900 | <1% | 89 | $243.46 | |
| 86901 | <1% | 89 | $241.24 | |
| 87899 | <1% | 24 | $220.22 | |
| 82150 | <1% | 39 | $217.89 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 589 | $217.65 |
| 87335 | <1% | 15 | $216.82 | |
| 87045 | <1% | 15 | $178.92 | |
| 83630 | <1% | 14 | $160.55 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $155.54 |
| 85610 | <1% | 66 | $154.31 | |
| 86706 | <1% | 15 | $145.50 | |
| 85027 | <1% | 46 | $128.60 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 95 | $125.90 |
| 87040 | <1% | 20 | $121.32 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $98.78 |
| 80076 | <1% | 12 | $91.96 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 196 | $83.75 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $66.48 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,052 | $58.55 |
| 85730 | <1% | 43 | $43.80 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 567 | $42.46 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 434 | $42.36 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 16 | $27.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 25 | $22.61 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 188 | $18.44 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 217 | $12.81 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,108 | $8.12 |
| A0425 | Ground mileage, per statute mile | 0% | 3,606 | $0.00 |
| A0429 | Emergency ambulance ride, basic life support | 0% | 545 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 16 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 28 | $0.00 |
| 31000 | 0% | 100 | $0.00 | |
| A0427 | Emergency ambulance ride, advanced life support | 0% | 1,772 | $0.00 |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 0% | 768 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNEWELL, DAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Highlands Hospitalists Services LLC | Scottsboro, AL | $207K |
| Jackson County Healthcare Authority | Bridgeport, AL | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.